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Abstract
Neutrophils are phagocytic innate immune cells that play essential roles in host defence, but
are also implicated in inflammatory diseases such as rheumatoid arthritis (RA) where they
contribute to systemic inflammation and joint damage. Transcriptomic analysis of neutro-
phils has revealed significant changes in gene expression in neutrophils activated in vitro by
cytokines and in vivo during inflammation in RA. However, there are no reports on the global
metabolomic changes that occur as a consequence of this activation. The aim of this study
was to establish protocols for the study of changes in the metabolome of human neutrophils
using 1H NMR spectroscopy. Sample preparation and spectral analysis protocols were opti-
mised using neutrophils isolated by Ficoll-Paque, with decreased washing steps and inclu-
sion of a heat-shock step to quench metabolite turnover. Cells were incubated ± PMA for 15
min in HEPES-free media and samples were analysed by NMR using a 700 MHz NMR
Avance IIIHD Bruker NMR spectrometer equipped with a TCI cryoprobe. Chenomx, Bruker
TopSpin and AMIX software were used to process spectra and identify metabolites. Princi-
pal Component Analysis (PCA) and signalling pathway analysis was carried out using Meta-
boanalyst. Cell number and number of scans (NS) were optimised as >3.6 million cells and
512 NS. 327 spectral bins were defined in the neutrophil spectra, of which 287 (87.7%) were
assigned to 110 metabolites that included: amino acids, peptides and analogues; carbohy-
drates, carbonyls and alcohols; nucleotides, nucleosides and analogues; lipids and lipid-like
molecules; benzenoids; and other organic compounds. 43 metabolites changed at least 1.5
fold (increase or decrease) after the addition of PMA for 5 or 15 min. Pathway analysis
revealed that PMA affected nicotinate and nicotinamide metabolism, aminoacyl-tRNA bio-
synthesis and glycolysis, suggesting a redirection of glucose metabolism from glycolysis to
the pentose phosphate pathway and production of NADPH for activation of the NADPH oxi-
dase and subsequent respiratory burst. We have developed protocols for the study of
human neutrophils by 1H NMR spectroscopy. Importantly, this methodology has sufficient
sensitivity and reproducibility to detect changes in metabolite abundance from cell numbers
typically collected from clinical samples or experiments with multiple assay conditions.
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Introduction
Neutrophils are immune cells that form the major arm of innate immunity, killing invading
microbes mainly through phagocytosis, granule enzyme activation and production of reactive
oxygen species (ROS)[1, 2]. In healthy individuals, neutrophils patrol the peripheral blood and
mucous membranes in an inactive or “resting state”, but upon infectious challenge can be rap-
idly primed by cytokines (such as GM-CSF and TNF) and toll-like receptor agonists. Priming
causes the rapid mobilisation of intracellular stores of receptors, including integrins, to the
plasma membrane to facilitate migration from peripheral blood towards the site of infection.
Subsequent activation at the site of infection, by engagement with complement proteins and/
or immunoglobulins on the surface of opsonised bacteria, initiates phagocytosis and bacterial
killing. This is normally followed by apoptosis of the neutrophil itself, which is then removed
by resident tissue macrophages[2]. However, in inflammatory diseases such as rheumatoid
arthritis (RA) neutrophils can be inappropriately primed and migrate towards sites of chronic
infection, such as synovial joints, where they become activated by immune complexes, releas-
ing ROS and proteases such as elastase directly onto host tissue leading to inflammation and
damage to joints[2–4]. Production of neutrophil extracellular traps (NETs) in RA and other
auto-immune conditions such as systemic lupus erythematosus (SLE), may lead to exposure of
intracellular antigens such as dsDNA and citrullinated peptides, contributing to the develop-
ment of auto-antibodies[3, 4]. NETs are also implicated in the inflammatory process, contrib-
uting to increased interferon-α production by plasmacytoid dendritic cells (pDCs) in SLE[5].
A recent resurgence in interest in metabolism in the context of immunity and inflammation
(immunometabolism) has led to an increased understanding of the complex changes in meta-
bolic regulation that take place in cells of the immune system during activation[6]. Changes in
cellular activation, such as migration from the bloodstream to sites of inflammation or differ-
entiation into tissue resident immune cells, can cause dramatic changes in nutrient and oxygen
availability and place high metabolic demands upon immune cells[6, 7]. For example, it has
been shown that M1 macrophages use glycolysis as their main source of energy, halting the
TCA cycle and oxidative phosphorylation during differentiation from monocytes, whereas M2
macrophages display low glycolytic activity, rather relying on fatty acid oxidation to fuel the
TCA cycle[7]. Fine-tuning of regulation of metabolic pathways during an inflammatory
response is key for the generation of small molecule metabolites such as ATP, NADPH, nucle-
otides and amino acids, which are required rapidly and in high abundance during cellular acti-
vation[6, 7]. Dysregulation of metabolic control has been identified in inflammatory diseases
such as rheumatoid arthritis[8], where changes in T cell glycolytic activity drives differentia-
tion, hyperproliferation and hypermigration of T cell subsets[8–10].
Currently, there are the two major platforms for metabolomics analysis: Nuclear Magnetic
Resonance (NMR) spectroscopy and Mass Spectrometry (MS)[11–13]. Whereas MS offers the
advantage of high sensitivity, the approach is often targeted and only identifies specific metabo-
lites of interest. In addition, MS requires the application of different chromatography techniques
if one wishes to identify different classes of molecules. NMR metabolomics, on the other hand,
offers a non-biased, non-separating approach to metabolic profiling which is faster and more
cost effective, and which does not lead to sample loss[14–16]. Indeed, samples can be stored and
re-run at a later date with a high level of reproducibility[17]. In addition, sample preparation for
NMR metabolomics is less technically challenging, without the need for columns or complex
optimisation[11], and reproducibility between different instruments is very good[18]. To date,
NMR metabolomics protocols for biofluids[19, 20] and cell pellets[21] have been described.
The study of human neutrophils in vitro presents a number of technical challenges meaning
that standard protocols for most assays must be optimised. Neutrophils are considerably more
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sensitive to manipulation than other cell types, and excessive centrifugation, agitation or
rough handling of neutrophils during isolation from whole blood can lead to unwanted activa-
tion, and importantly, preparation protocols must take into account final cell purity, which
should be free of contaminating PBMCs[22, 23]. Neutrophils must be isolated from whole
blood within 1h of venepuncture to preserve the functional integrity of the cells and prevent
cell death. Neutrophils are terminally differentiated cells and as such are short-lived, particu-
larly in culture, with a life-span of less than 24h in vitro[2]. Neutrophils have lower levels of
transcriptional activity compared to other leukocytes, and consequently, gene expression stud-
ies often have to use numbers of neutrophils at least ten-fold greater than other primary
human cells or cell lines[22]. The level of metabolic activity in neutrophils compared to other
primary human cells is unknown, but presumed lower, particularly in healthy, non-activated
neutrophils. Intracellular reactions associated with neutrophil priming and activation occur in
a matter of seconds[24], and so analysis of samples taken after suitable experimental time
points are an important consideration when planning metabolomics experiments to detect
neutrophil function. For example, one of the hallmarks of neutrophil function is the activation
of the normally dormant NADPH oxidase during phagocytosis or other forms of activation,
which can result in large changes in the NADP/NADPH ratio very rapidly after cell stimula-
tion[1, 25]. This activation occurs rapidly, is sustained for several minutes and then declines.
This is likely to be accompanied by transient and rapidly changing metabolic profiles.
The overall aim of this study was to optimise protocols for 1H NMR metabolomics to
study changes in neutrophil metabolomics profiles during various forms of in vivo or in vitro
activation. In particular, it was necessary to establish protocols to optimise sample prepara-
tion, metabolite extraction, and analysis that minimised the chemical and physical degrada-
tion of neutrophil metabolites and avoided the introduction of interfering compounds
commonly used in isolation procedures. Importantly, we wanted to optimise our protocols
for low amounts of starting material (<5 million neutrophils) to enable translation of the
technology into clinical research, where ethical and practical restrictions often mean only
small volumes of blood are available for analysis, particularly from paediatric samples. A
recent application of NMR metabolomics to the study of neutrophils required at least 20 mil-
lion cells per condition for metabolite extraction[26], which is in excess of the cell numbers
routinely available from clinical studies. Our optimised protocol presented here has enabled,
for the first time, metabolic profiling of less than 5 million neutrophils using NMR metabolo-
mics. As there is no excessive preparation time required, this approach is capable of detecting




HetaSep solution was from StemCell (Cambridge, UK); Ficoll-Paque was from GE Healthcare
(Little Chalfont, UK); RPMI 1640 media was from Life Technologies (Paisley, UK); phorbol
12-myristate 13-acetate (PMA) and NADP was from Sigma (Gillingham, UK); HPLC grade
acetonitrile (Thermofisher, UK), d4 trimethylsilyl propionate (TSP), and NaN3 (Sigma, Gil-
lingham, UK).
Neutrophil isolation
This study was carried out in accordance with the recommendations of the University of Liver-
pool Committee on Research Ethics. The protocol was approved by the University of Liverpool
Committee on Research Ethics. All healthy subjects (4 males, 1 female, age range 25–57) gave
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written informed consent in accordance with the Declaration of Helsinki. Whole blood was
collected into lithium-heparin vacutainers; the use of EDTA as an anticoagulant was avoided
because extra resonance signals are observed in the NMR spectrum via the formation of com-
plexes between EDTA and Ca2+ and Mg2+ present in plasma[13, 27]. Neutrophils were isolated
within 15 min of blood collection. Whole blood was mixed with HetaSep solution at a ratio of
1:5 (HetaSep:whole blood) and incubated at 37˚C for 30 min until the plasma/erythrocyte
interphase was at approximately 50% of the total volume. The erythrocyte-free phase contain-
ing all nucleated blood cells was collected, and carefully layered on top of Ficoll-Paque solution
at a ratio of 1:1, and then centrifuged at 500 g for 30 min. The peripheral blood mononuclear
cells (PBMC) layer, plasma, and Ficoll-Paque solution, were carefully removed, leaving a neu-
trophil pellet (purity typically >97%)[22, 28–30]. The pellet was resuspended in RPMI-1640
media with 25 mM phosphate buffer pH 7.4. Remaining erythrocytes were removed by hypo-
tonic lysis with ammonium chloride buffer for 3 min, and then centrifuged at 400 g for 3 min.
The supernatant was removed, and neutrophils were re-suspended in RPMI-1640 with 25 mM
phosphate buffer pH 7.4. Neutrophils were activated by the addition of phorbol 12-myristate
13-acetate (PMA, 0.1 μg/mL).
Sample preparation for intracellular metabolite extraction
Our modified protocol to isolate neutrophils for metabolite extraction, was determined after a
series of pilot studies. Steps that were deemed important for optimisation for the metabolomics
pipeline, were briefly as follows (see Results section for detailed analysis): (1) To optimise the
neutrophil cell number and the number of scans (NS), three different total cell numbers of
neutrophils (2.5, 3.6 and 9.7 x 106 cells per sample), were analysed using an increasing number
of scans (NS) 128, 256, 512, 1024 and 2048. Analysis of technical triplicate samples was then
performed to determine the reproducibility of spectral data in each experiment. (2) To opti-
mise quenching of neutrophil metabolism by heating neutrophils prior to the snap freezing,
107 healthy neutrophils were collected either with or without a heating step prior to the collec-
tion of cell pellet. The heating step was exposure of cell pellet to 100 oC for 1 min, immediately
before snap-freezing. (3) To determine any loss of NADP during sample preparation for
NMR, purified NADP was added into the samples under three different conditions. First,
10 μg NADP (in 50 μL PBS) was added into the cell pellets of 9.7 x 106 neutrophils before the
heating steps. The cell pellets then went through the extraction and lyophilisation procedures.
Second, 10 μg NADP was added to 50 μL PBS (no cell pellets). The NADP-spiked samples
were then heat shocked, and extracted and lyophilised. Third, 20 μg NADP (in 200 μL PBS),
without any processing, was analysed as a positive control.
To prepare cell pellets for metabolite extraction, neutrophils were centrifuged at 1000 g at
25 oC for 2 min. The supernatant was aspirated, and cell pellets were resuspended with ice-
cold PBS, then centrifuged at 1000 g at 25 oC for 2 min. The supernatant was discarded, while
the pellets were heated at 100 oC for 1 min, and then were snap-frozen in liquid nitrogen. All
samples were stored at -80 oC prior to intracellular metabolite extraction.
Intracellular metabolite extraction
Cell samples were extracted by addition of 50:50 v/v ice cold HPLC grade acetonitrile:water at
500 μL per cell pellet (a constant volume irrespective of pellet size), followed by a 10 min incu-
bation on ice. Then samples were sonicated three times for 30 s at 23 kHz and 10 μm ampli-
tude using an exponential probe, with 30 s rest between sonications in an ice water bath.
Sonicated samples were centrifuged at 12000 g for 5 min at 4˚C and the supernatant trans-
ferred to cryovials, flash frozen in liquid N2 and lyophilised[13].
Metabolic profiling of human neutrophils
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Sample preparation for NMR
Each lyophilised sample was resuspended in 200 μl of 100 mM deuterated sodium phosphate
buffer pH 7.4, with 100 μM d4 trimethylsilyl propionate (TSP) and 0.05% NaN3. Each sample
was vortexed for 20 s and centrifuged at 12000 g for 1 min at 20˚C. 180 μl of each cell extract
sample was transferred to 3 mm (outer diameter) NMR tubes for acquisition.
NMR acquisition and spectral processing
The samples were acquired using a 700 MHz NMR Avance IIIHD Bruker NMR spectrometer
equipped with a TCI cryoprobe. Samples were referenced to trimethylsilylpropanoic acid
(TSP) at 0 ppm. Chenomx, Bruker TopSpin and AMIX software were used to identify metabo-
lites and process spectra. Samples were analysed using the 1D Carr-Purcell-Meiboom-Gill
(CPMG) edited pulse sequence technique (to selectively detect low molecular weight metabo-
lites, less than 1,000 Da in the acquired spectra). Different total cell numbers of neutrophils
(2.5, 3.6 and 9.7 x 106 cells per sample), were analysed decreasing signal-to-noise while increas-
ing experiment time using an increasing number of scans (NS), i.e. 128, 256, 512, 1024 and
2048, requiring 15 min, 30 min, 1h, 2h and 4 h acquisition time per sample, respectively. Tem-
perature was calibrated to 25 oC (with margin of error of 0.1 oC) via a methanol thermometer
[31] prior to each day of acquisition; receiver gain was kept constant for all acquisitions. Spec-
tra were automatically phased, referenced and baseline corrected in Topspin 3.1 via apk0.noe
routine (Bruker, UK). Metabolomics data have been deposited to the EMBL-EBI MetaboLights
database[32] with the identifier MTBLS658. The complete dataset can be accessed here:
https://www.ebi.ac.uk/metabolights/MTBLS658.
Spectra processing and quality control
The spectra were assessed to conform to minimum quality criteria as outlined by the Metabo-
lomics Society[33] to ensure consistent linewidths, baseline corrections and water suppression.
All spectra passing quality criteria were then divided into ‘buckets’ or ’bins’ that were defined
globally by the peak limits using Amix1 software. All peaks, both annotated in Chenomx (via
manual analyses in TopSpin and Chenomx software) and unknown, were included in the
bucket table (see example spectra in S1 Fig and metabolite annotations in S1 Table).
Metabolite annotation and identification
Metabolites in the 1H NMR spectra were initially tentatively annotated using the metabolite
discovery software Chenomx (Chenomx, Canada) and, where possible, their identities con-
firmed using an in-house library of metabolite spectra[34]. Annotation level is indicated in the
Metabolights deposition.
Metabolomics statistical analysis
Statistical analyses were performed using the online programme, Metaboanalyst1 3.0 (http://
www.metaboanalyst.ca/)[35, 36], which uses the R package of statistical computing software.
The bucketed experimental data were normalised by the total spectral intensity and addition-
ally Pareto scaled (for multivariate analysis). NMR data were found to show a normal distribu-
tion and therefore no data transformation was required. Univariate analysis was by ANOVA
with application of a False-Discovery Rate (FDR) adjusted p-value of 0.05. Multivariate analy-
sis was via unsupervised Principal Component Analysis (PCA) followed by Partial Least
Squares Discriminant Analysis (PLS-DA) validated via leave one out cross-validation to auto-
matically determine optimal number of components as well as the quality of the model
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(described in terms of accuracy, R2 and Q2). Hierarchical cluster analysis was carried out
using MeV[37] using Euclidean clustering and average linkage.
Metabolomics pathway analysis
Pathway analysis was carried out using the list of significantly different metabolites between
PMA-treated and untreated neutrophils using Metaboanalyst1 and the methodology of
Metabolite Set Enrichment Analysis[36, 38], with reference to the KEGG (Kyoto Encyclopedia
of Genes and Genomes) metabolic pathway database (http://www.kegg.jp/kegg/pathway.html)
for human metabolic pathways[36] and current understanding of biochemical pathways[39].
Pathway enrichment was determined by Hypergeometric test and reported with an FDR-
adjusted p-value.
Results
Optimising protocols for NMR metabolomics analyses of human
neutrophils
No established protocols have yet been developed for the measurement of the metabolomic
profiles of<5 million human neutrophils using NMR. Our first objective was to optimise
these procedures in view of both the challenges and the potential advantages of different proto-
cols, and of the difficulties in working with human neutrophils at the low cell numbers that
may be obtained from clinical samples. Also, in light of the very rapid and transient nature of
changes in neutrophil metabolism following stimulation, we wanted to develop a rapid and
efficient extraction methodology with minimal perturbation.
Minimising processing time and wash steps
During the isolation process, all washing steps were minimised as much as appropriate without
compromising the numbers of cells collected or carry over of media. For example, the washing
step after centrifugation in Ficoll-Paque reagent was eliminated. In order to investigate the
effect of washing steps, the neutrophil suspensions were equally distributed into two tubes, at a
concentration of 3.5x106 cells/mL in 3mL of RPMI-1640 media. Both tubes were centrifuged
at 500 g for 3 min. In one tube (washed sample), the supernatant was discarded and 3 mL
RPMI-1640 media was added. After the red blood cell lysis step, the cell pellet was resuspended
and recounted. The cell concentration had decreased to 3x106 cells/mL. In another tube (non-
washed sample), the supernatant was not discarded but was used again to resuspend the cell
pellet. The cell suspensions were then aliquoted into three tubes for technical replicates. The
NMR spectra were visibly different, and metabolite loss was clearly evident in the washed sam-
ple (Fig 1A). Variation between technical replicates was also visibly greater in samples includ-
ing a wash step, indicating loss of cells and/or metabolites during washing. Direct observation
of contributing peaks from contaminating Ficoll-Paque was not present in the spectra (S1 Fig).
Use of HEPES as media buffer
NMR metabolomics has the potential to detect intracellular metabolites at very low levels, for
example as low as 500 ng of pure compound[40]. However, these low quantity metabolites are
detected as low intensity peaks, which can be easily obscured by the presence of high concen-
tration metabolites, some of which may commonly be contaminants. As the NMR technique is
a very sensitive tool, all possible contaminants, including chemicals and disinfectants used in
cell preparation/isolation, were considered and then eliminated from the isolation/extraction
protocol, wherever possible. RPMI media with HEPES buffer is routinely used in our normal
Metabolic profiling of human neutrophils
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protocols for the preparation of human neutrophils, in order to maintain the pH of the media
around 7.2–7.5, and maintain viable, unactivated human neutrophils[41, 42]. Moreover,
altered pH of the samples could influence the chemical shifts of the NMR spectrum[43]. How-
ever, residual HEPES in the neutrophil extracts (from the RPMI medium) is undesirable, due
to the buffer exhibiting multiple high peaks, in the 1H NMR spectra (Fig 1B). Therefore, in all
subsequent experiments, 25 mM phosphate buffer was added into the media in place of
HEPES, to maintain the pH at 7.4. Phosphate buffer does not give rise to 1H NMR signals[13],
thus not impacting the overall NMR spectrum, and as such phosphate buffer was used in all
subsequent neutrophil NMR metabolomics experiments.
Fig 1. Optimisation of neutrophil isolation protocols for NMR metabolomics. (A) Spectra (n = 3) shown for neutrophil isolation protocols including
(grey spectra) or omitting (red spectra) a wash step immediately after Ficoll-Paque separation. Metabolite loss in the washed samples is indicated by
arrows. (B) Spectra (n = 3) show neutrophils incubated with media containing phosphate buffer (red spectra) or HEPES buffer (grey spectra). Multiple
contaminating peaks from HEPES are indicated by arrows. (C) Spectra (n = 3) are shown for sample preparation including (grey spectra) or excluding
(red spectra) a heat-shock step immediately prior to snap freezing of pellet. Metabolite degradation/turnover was prevented by heat shock as indicated
by arrows.
https://doi.org/10.1371/journal.pone.0209270.g001
Metabolic profiling of human neutrophils
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Heat quenching of metabolites prior to extraction
We next determined the effect of quenching neutrophil metabolism by heating neutrophils
prior to snap freezing. In these experiments, neutrophils were heated to 100 oC for 1 min in
order to denature metabolic enzymes (which could be released during extraction) and hence
stabilise all metabolites, protecting them from further cellular reactions. Neutrophils were
incubated with the protein kinase C activator phorbyl 12-myristate 13-acetate (PMA, 0.1 μg/
mL) for 10 min to stimulate metabolic activity and production of ROS, after which heat shock
was applied to one sample while another sample was extracted without the heat shock treat-
ment. Heat shock treated samples demonstrated overall higher levels of metabolites than spec-
tra obtained from the samples extracted without the heat shock step (Fig 1C).
Cell number and number of scans
Finally, optimisation of neutrophil cell number was necessary, as the total numbers of neutro-
phils that can be routinely obtained from the blood or biofluids of patients and healthy donors
can be low. For clinical samples, particularly from paediatric patients, the total number of neu-
trophils obtained from a single blood sample may be as low as 2x106 cells. Therefore, it was
critical to determine the minimum number of neutrophils required to detect the highest possi-
ble number of metabolites in the NMR spectra and to generate optimal signal-to-noise ratio.
Neutrophils were prepared in technical triplicates at three different cell numbers (2.5, 3.6
and 9.7x106 cells) and analysed using five different numbers of scans (NS) (128, 256, 512, 1024
and 2048). The non-destructive nature of NMR metabolomics meant that we were able to run
the same samples at five different NS for this optimisation step. Analysis of the signal to noise
(S/N) ratio showed a significant increase in S/N with the increasing NS. This became signifi-
cant for all cell concentrations at 512 NS (Fig 2A p<0.0001 ANOVA, post-hoc �p<0.05,
��p<0.01, ���p<0.001).
Detection of low-level metabolites
Neutrophils possess sophisticated mechanisms for the phagocytosis and killing of bacteria.
These include the generation of ROS via the NADPH oxidase, which is rapidly activated dur-
ing cell stimulation[1]. In order to fuel the NADPH oxidase, dynamic and rapid changes in the
concentrations and ratios of NAD, NADP and NADPH take place during neutrophil activa-
tion. In our preliminary experiments (at 256 NS), the spectral peaks representing NAD and
NADP were barely detectable (S2 Fig). Therefore, experiments with increased signal-to-noise
were analysed to determine whether the detection of the NAD spectral peaks could be
enhanced. The study revealed the presence of more prominent NAD and NADP spectral
Fig 2. Optimisation of cell number and number of scans required for neutrophil metabolomics. Principle Component Analysis was carried out on triplicate samples
of different neutrophil cell concentrations (A) 2.5x106, (B) 3.6x106 and (C) 9.7 x 106 cells. Each sample was measured at an increasing number of scans: 128, 256, 512,
1024 and 2048. Significant increase in signal to noise (S/N) was observed at 512NS (ANOVA with Tukey’s post-hoc test, n = 3, �p<0.05, ���p<0.001).
https://doi.org/10.1371/journal.pone.0209270.g002
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peaks at 4096 scans for minimal number of cells (2.5 x 106 cells). Using this approach, NAD
and NADP were detected, but still at low levels. We found that by increasing the cell concen-
tration to�3.6 million cells and increasing the number of scans to 512, not only could we
detect NAD and NADP in neutrophil extracts, but importantly a change in the ratio of NAD
to NADP was clearly observed when samples were treated with PMA (Fig 3).
NMR Metabolomics analysis of healthy human neutrophils
Metabolomic analysis of unactivated and activated healthy human neutrophils. In
order to determine the metabolite profile of unactivated, healthy neutrophils and investigate the
metabolic changes that take place when neutrophils are activated, we stimulated healthy neutro-
phils with PMA (0.1 μg/mL) for 5 and 15 min. Metabolites were extracted from unactivated and
PMA-activated neutrophils as per our optimised protocol described above. The NMR spectra
were divided into 327 spectral bins (based on representative spectra from samples +/- PMA
treatment), of which 287 (87.7%) were assigned to 110 metabolites including: amino acids, pep-
tides and analogues; carbohydrates, carbonyls and alcohols; nucleotides, nucleosides and ana-
logues; lipids and lipid-like molecules; benzenoids; and other organic compounds (Table 1).
Univariate analysis of 5 min and 15 min timepoints ± PMA identified 12 spectral buckets that
were significantly increased or decreased after PMA treatment (FDR<0.05, Table 2). The
metabolites represented by the significantly changing spectral buckets were ADP and aspartate
and/or homocysteine as well as some unidentified metabolites. Fifty-four spectral buckets had a
fold-change in abundance (increase or decrease) of at least 1.5 fold at 5 or 15 min post PMA
treatment, including NAD, NADP and NADPH. The levels of NAD and NADP decreased by
-1.8 and -1.6 fold respectively, whereas NADPH increased by 1.7 fold with 15 min PMA
Fig 3. Detection of NAD and NADP+ in neutrophil spectra. Neutrophils were incubated in the absence or presence of PMA (0.1 μg/mL) for 15
min. An increase in the ratio of NADP+ to NAD was observed after addition of PMA. Spectral peaks for NAD (blue arrow) and NADP+ (red arrow)
are shown in both neutrophil preparations (+/- PMA) and cell-free standards.
https://doi.org/10.1371/journal.pone.0209270.g003
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treatment. Several of these buckets related to multiple spectral peaks from the same metabolite,
for example NAD was represented by four different buckets, and some single buckets were
assigned to multiple metabolites, for example alanine and isoleucine (Fig 4, S3 Fig, S1 Table). In
addition, the levels of many metabolites changed over 15 min in untreated neutrophils, in-
cluding aspartate, lactate and NADPH which decreased, and NAD and NADP which increased
(Fig 4).
Table 1. List of 110 metabolites detected in healthy neutrophils by 1H NMR spectroscopy (n = 5 biological
replicates).
Amino acids, peptides, and analogues
1-Methylhistidine, 3-Methylhistidine, Acetylglycine, Betaine, Dimethylglycine, gamma-Glutamylphenylalanine,
Glutathione, Glycine, L-Alanine, L-Aspartic acid, L-Glutamic acid, L-Histidine, Homocysteine, Isovalerylglycine,
L-Isoleucine, L-Phenylalanine, L-Tyrosine, L-Valine, N-Acetyl-L-aspartic acid, N-Acetyl-L-tyrosine, N-Alpha-
acetyllysine, N-Phenylacetylphenylalanine, Phenylacetylglycine, Saccharopine
Carbohydrates, carbonyls and alcohols
Beta-N-Acetylglucosamine, Dihydroxyacetone, D-Glucose, D-Glucuronic acid, D-Mannose, Erythritol, Ethanol,
Lactulose, L-3-Hydroxykynurenine, L-Kynurenine, Methanol
Nucleosides, nucleotides, and analogues
ADP, AMP, ATP, Cytidine, dADP, dIDP, Guanosine, Guanosine triphosphate, Inosine, NAD, NADH, NADP,
NADPH, Nicotinic acid adenine dinucleotide, S-Adenosylhomocysteine, Uridine diphosphate-N-
acetylglucosamine, Uridine diphosphate glucose, Uridine diphosphate glucuronic acid, Uridine 5’-diphosphate,
Uridine 5’-monophosphate
Lipids and lipid-like molecules
2-Hydroxy-3-methylbutyric acid, 2-Hydroxyvaleric acid, 3-Hydroxyisovaleric acid, 3-Hydroxymethylglutaric acid,
3-Methyladipic acid, Methylsuccinic acid, Monomethyl glutaric acid, Thymol
Benzenoids (benzene derivatives and phenols)
3-Hydroxymandelic acid, 3-Hydroxyphenylacetic acid, 4-Aminohippuric acid, Acetaminophen, Homovanillic acid,
o-Cresol, Ortho-Hydroxyphenylacetic acid, p-Cresol, Phenylacetic acid, p-Hydroxyphenylacetic acid, Salicylic acid,
Syringic acid, Tyramine, Vanillylmandelic acid
Other organic compounds
1,3-Dimethyluric acid, 2-Ketohexanoic acid, 3-Methylxanthine,5-Hydroxyindoleacetic acid, 5-Hydroxy-L-
tryptophan, Acetamide, Acetic acid, Adenine, Anserine, Carnosine, Choline, Desaminotyrosine, Formic acid,
Histamine, Hypoxanthine, Indoxyl sulfate, Imidazole, Indoleacetic acid, Indolelactic acid, Isocitric acid,
L-Carnitine, L-Lactic acid, Levulinic acid, Methylmalonic acid, Niacinamide, N,N-Dimethylformamide,
Oxypurinol, Phenyllactic acid, Phosphorylcholine, Pyridoxine, Riboflavin, Taurine, Xanthine
https://doi.org/10.1371/journal.pone.0209270.t001









Unknown + + 9.6783 6.8x10-8
ADP + + 6.0101 1.6x10-4
Oxypurinol/ADP + + 5.7127 2.1x10-4
ADP or ATP + + 5.4374 2.9x10-4
Unknown + + 5.1849 4.6x10-4
Homocysteine/Aspartate + + 4.8621 7.5x10-4
Homocysteine/Aspartate/Anserine + 4.5884 1.2x10-3
ATP/Unknown + + 4.537 1.2x10-3
Aspartate + + 4.4519 1.3x10-3
Aspartate + + 3.3857 1.3x10-2
Unknown + + 2.851 4.2x10-2
N-acetylaspartate/homocysteine/unknown + + 2.7527 4.8x10-2
+ = metabolite significantly altered
https://doi.org/10.1371/journal.pone.0209270.t002
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Fig 4. Heatmap of metabolites with at least 1.5-fold change (increase or decrease) from 0h following treatment with
or without PMA for 5 and 15 min. Ace = acetate, AcTyr = acetyltyrosine, Ade = adenine, ADP = adenosine diphosphate,
Ala = alanine, AmHip = aminohippurate, Asp = aspartate, Ery = erythritol, Eth = ethanol, DMF = dimethylformamide,
Form = Formate, Gly = glycine, Hist = histamine, Hpx = hypoxanthine, Ile = isoleucine, Imi = imidazole, Ino = inosine,
Lac = lactate, Lcl = lactulose, Levu = levulinate, Man = mannose, MeAdp = methyladipate, MeHist = methylhistidine,
MeMal = methylmalonate, MeXan = methylxanthine, NAAD = nicotinic acid adenine nucleotide, NAD = nicotinamide
adenine dinucleotide, NADP = nicotinamide adenine dinucleotide phosphate, NADPH = nicotinamide adenine
dinucleotide (reduced), OxyP = oxypurinol, Unk = unknown. Mean fold change shown for n = 2 or 3 biological replicates
measured in technical triplicates.
https://doi.org/10.1371/journal.pone.0209270.g004
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Multivariate analysis of activated neutrophils. Multivariate analysis (PLS-DA, partial
least square discriminant analysis, 5 components) showed that when neutrophils were treated
with PMA, the metabolic profile changed significantly, as evidenced by the quality of discrimi-
nation between 0 and 5 min (Fig 5A, Q2 0.7932, R2 0.9685, accuracy 0.9444) and 0 and 15 min
(Fig 5B, Q2 0.93712, R2 0.98421, accuracy 1.0) whereas differences between 5 and 15 min of
PMA treatment were less distinct (S4 Fig, Q2 0.39248, R2 0.91143, accuracy 0.83333). It should
be noted that the metabolome of untreated neutrophils changes over time, as can be seen from
the analysis of untreated cells at 0 and 5 min (Fig 5D, Q2 0.32754, R2 0.8382, accuracy 0.8) or 0
and 15 min (Fig 5E, Q2 0.66767, R2 0.9411, accuracy 0.86667); however the model for 5 and 15
minutes for untreated cells did not distinguish the two groups (S5 Fig, Q2–6.4346, R2 0.93566,
accuracy 0.16667). Discriminant analysis of PMA treated neutrophils versus untreated neutro-
phils modelled differences at 5 min (Fig 5G, Q2 0.64496, R2 0.92841, accuracy 0.93333) and 15
min (Fig 5H, Q2 0.64488, R2 0.98587, accuracy 0.93333). Comparison of 0 min vs PMA at 5
min and PMA at 15 min also clearly indicates the time-dependent effect of PMA on metabo-
lism (Fig 5I, Q2 0.79897, R2 0.93934, accuracy 0.66667) with Variable Influencing Projection
(VIP) analysis indicating influential metabolites for this separation are increasing levels of lac-
tate, glucose and 3-hydroxykyneurinine, and decreasing levels of acetate, methylmalonate,
3-methyladipate and taurine (Fig 5J). Of note, the levels of glucose rapidly increased from 0h
to 5 min following PMA stimulation, and then fell again following 15 min PMA stimulation.
Biological context. Pathway analysis revealed that the most significant metabolomic
changes in PMA-activated neutrophils involved nicotinate & nicotinamide metabolism, ami-
noacyl-tRNA biosynthesis and glycolysis (Table 3). We combined the results of the pathway
analysis with our univariate and multivariate analyses into a single metabolic flow diagram
(Fig 6) to enable interpretation of the interactions between the metabolites and the different
Fig 5. Change in neutrophil metabolome induced by PMA. Neutrophils were incubated in the presence (A,B,E,F,G) or absence (C,D,E,F) of PMA
(0.1 μg/mL) for 5 (A,C,E,G) and 15 min (B,D,F,G) (n = 2 or 3 biological replicates measured in technical triplicates). Supervised multivariate analysis
by PLS-DA segregated PMA-treated samples. Shading represents 95% confidence region. Scores plot is shown for components 1 and 2. (H) Variable
Importance in Projection (VIP) analysis suggested influential metabolites for this separation are increasing levels of lactate, glucose and
3-hydroxykyneurinine, and decreasing levels of acetate, methylmalonate, 3-methyladipate and taurine.
https://doi.org/10.1371/journal.pone.0209270.g005
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metabolic pathways. Our analysis revealed a redirection of metabolic activity from glycolysis
to the pentose phosphate pathway (PPP) and the phosphoribosyl pyrophosphate pathway
(PRPP) when neutrophils were activated by PMA. Both the PPP and the PRPP fuel ROS pro-
duction via the NADPH oxidase and xanthine oxidase respectively.
Discussion
The aim of this research was to develop protocols for the study of human neutrophils using
1H NMR metabolomics. We decided to use the NMR methodology to study neutrophil meta-
bolomics, as this technique, unlike mass spectrometry-based techniques, allows quantitative
analyses of untargeted metabolomics profiles. NMR spectra of biofluids and pattern recogni-
tion methods in metabolomics has enabled the identification and quantitation of metabolites
Fig 6. Pathway scheme depicting metabolite changes during neutrophil activation with PMA. Metabolites shown in blue decreased following PMA
stimulation and metabolites shown in red increased; gradient red/blue shading represents an increase following 5 min and then a decrease by 15 min
with PMA activation, and vice versa. Metabolites shown in white were not detected but are key components of the pathway.
https://doi.org/10.1371/journal.pone.0209270.g006
Table 3. Pathway analysis of metabolites changing 1.5 fold in the presence of PMA.
Hits/Total P value FDR
Nicotinate & nicotinamide metabolism 4/44 2.13x10-3 0.092617
Aminoacyl-tRNA biosynthesis 5/75 2.32x10-3 0.092617
Glycolysis or Gluconeogenesis 3/31 6.81x10-3 0.18172
Nitrogen metabolism 3/39 1.29x10-2 0.25847
Taurine & hypotaurine metabolism 2/20 2.64x10-2 0.36115
Purine metabolism 4/92 2.85x10-2 0.36115
Selenoamino acid metabolism 2/22 3.16x10-2 0.36115
Alanine, aspartate & glutamate metabolism 2/24 3.72x10-2 0.37161
Phenylalanine, tyrosine & tryptophan biosynthesis 2/27 4.61x10-2 0.39444
beta-Alanine metabolism 2/28 4.93x10-2 0.39444
https://doi.org/10.1371/journal.pone.0209270.t003
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in different biological samples including biofluids such as urine[19], serum[20] and synovial
fluid[44], and in cell pellets[21] including neutrophils[26], thus providing highly informative
data about the functional state of living organisms, including humans.
A key aim of our study was to develop protocols to allow the measurement of metabolites
in neutrophils isolated from low volumes of blood (<5 million neutrophils) to enable future
analysis of clinical samples, which are often low in volume. As such our optimised protocol dif-
fers from that recently published which requires 20 million neutrophils for metabolite extrac-
tion[26]. We were able to prevent metabolite loss by decreasing the number of wash steps
during the neutrophil isolation protocol and, importantly, inclusion of a heat shock step prior
to metabolite extraction. Protocols were developed to take into account of the low levels of
metabolites in human neutrophils, and to develop optimal conditions for the detection of
metabolites such as NADP, which have high rates of turnover during activation of neutrophils.
We also considered ways to minimise undesirable activation of neutrophils during the isola-
tion protocol. In order to optimise protocols for neutrophil metabolomics, it was necessary to
study both unactivated (freshly-isolated healthy control) and activated neutrophils.
It was decided to use PMA as the activating factor for in vitro optimisation experiments.
PMA is an analogue of diacylglycerol, which rapidly activates protein kinase C (PKC), generat-
ing a respiratory burst through activation of the NADPH oxidase[45]. It is used experimentally
to activate ROS production (via the respiratory burst) from primed and unprimed neutrophils,
and is a potent activator of neutrophil extracellular trap formation (NETosis)[29, 46, 47]. The
major changes in metabolism observed in PMA-treated neutrophils centred around the glycoly-
sis pathway. A dynamic regulation of glucose levels in neutrophils in response to PMA was
observed; after 5 min PMA treatment glucose levels increased compared to 0h neutrophils, and
after 15 min glucose levels were lower compared to 5 min with PMA-stimulation. This likely
represents a rapid import of glucose from culture media at 5 min (or else glycogenolysis[48]),
and then rapid metabolism of glucose by 15 min via the pentose phosphate pathway (PPP) (also
called the hexose monophosphate shunt). The PPP is a key pathway in the dehydrogenation of
NADP to NADPH, with NADPH being the key electron donor for ROS production via the
NADPH oxidase. We observed decreases in the abundance of downstream metabolites of gly-
colysis (e.g. isoleucine, alanine, formate, acetate and ethanol) following PMA stimulation, con-
firming the redirection of glucose metabolism to the PPP to fuel NADPH production for rapid
activation of the NADPH oxidase leading to ROS production. Whilst pathway analysis pre-
dicted the decrease in these metabolites may be related to gluconeogenesis, is has previously
been established that neutrophils are unable to produce glucose via gluconeogenesis[49], and
that their glucose supply is provided solely via uptake from the blood or culture media or glyco-
genolysis[48]. The high levels of lactate observed in our study appear to support this theory, as
lactate is the main substrate for gluconeogenesis[39]. A decrease in hypoxanthine may also indi-
cate ROS production via xanthine oxidase (XO)[39] in response to PMA. Oxypurinol, an inhib-
itor of XO-derived ROS was also decreased by PMA-stimulation. Ambiguity in metabolite
association with specific pathways was mitigated by metabolite set enrichment analysis. Never-
theless, incomplete databases[50] may lead to gaps in the association of metabolites with certain
pathways, and it is clear that lactate, hypoxanthine and oxupurinol are associated with many
metabolic pathways (Human Metabolome Database (HMDB)[51–54] accession numbers
HMDB0000190, HMDB0000157 and HMDB0000786 respectively).
No metabolites relating to the TCA cycle were detected in this study. Unlike other leuko-
cytes, neutrophils obtain all their energy via aerobic glycolysis[55–57] and the TCA cycle is
entirely absent. Moreover, neutrophil mitochondria maintain transmembrane potential via
the glycerol-3-phosphate shuttle rather than oxidative phosphorylation and lack respiratory
chain super-complex organisation[57]. As a consequence, neutrophil mitochondria contribute
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little to ATP synthesis[48] and function predominantly in the regulation of apoptosis and
migration[58, 59]. In the presence of glucose, ATP is generated from lactate produced during
glycolysis. The disappearance of ATP during neutrophil functions such as phagocytosis is irre-
versible, with no detectable increase in ADP or AMP[48]. PMA has previously been shown to
increase lactate production[46] in line with the findings of our study. Metabolic reprogram-
ming of neutrophils to aerobic glycolysis during maturation enables these cells to survive at
sites of inflammation, which typically have low oxygen tensions, preventing synthesis of ATP
via oxidative phosphorylation[56].
PMA is a well-described agonist of neutrophil extracellular trap (NET) production in vitro
[46, 47]. NET production in response to PMA has been demonstrated to be dependent upon
glucose and glycolysis; in the absence of glucose, or during glycolysis inhibition, PMA induced
chromatin decondensation but failed to induce NET release. Notably, the addition of glucose,
but not pyruvate, was able to reinstate NETosis in these experiments[46]. NET production
requires a shift in glucose metabolism to the PPP via glucose-6-phosphate dehydrogenase
(G6PD)[60]. G6PD activity increases following PMA treatment via the action of PKC which
phosphorylates serine and tyrosine residues neighbouring the active site of G6PD[61], and
when G6PD activity is blocked NET production is abrogated. Glucose entering a neutrophil is
phosphorylated by hexokinase to glucose-6-phosphate which can then flow through two path-
ways: PPP (producing NADPH and 6-phosphogluconolactone) or glycolysis (producing ATP
and lactate). Production of NETs requires activation of the NADPH oxidase and production
of ROS as well as mobilisation of granule enzymes such as elastase to the nucleus, leading to
decondensation of nuclear chromatin prior to the release of extracellular DNA[3]. PMA has
been shown to induce ROS production in glucose-free media[60]; however this was signifi-
cantly lower than ROS produced in the presence of glucose. In the presence of a NOX2 inhibi-
tor, PMA can induce low amounts of ROS, possibly via mitochondrial superoxide dismutase
activity. However, mitochondrial ROS alone are not sufficient to trigger NET production[60],
and neutrophils do not rely on mitochondrial function for NET release[46]. A number of
amino acids and their intermediates were increased or decreased following PMA stimulation.
This may represent a stimulation of transcription and translation in response to PMA[47],
and/or the depletion of amino acids as glucose is re-directed from anaerobic glycolysis towards
the PPP [56].
Our study is one of only two reporting global analysis of metabolites in human neutrophils.
A recent study by Richer et al. [26] compared the metabolite profile of cytokine-treated neu-
trophils with that of untreated neutrophils and aged (30h) neutrophils. In this study, which did
not include a heat-shock step, the authors report very low detection of transient metabolites
NAD and NADPH in freshly isolated and cytokine-treated neutrophils, although high levels of
NAD were detected in aged apoptotic neutrophils. Many of the other metabolites reported cor-
relate well with the metabolites identified in our study, although they do not report the full list
of annotated metabolites from their experiments, or state the number of annotated spectral
bins.
Conclusions
In summary, our results show that NMR metabolomics has great potential to identify func-
tional changes in neutrophils activated in vitro or in vivo during inflammation. The metabolo-
mics changes identified correlate well with the known and predicted changes in function of
these cells and further work is now needed to perform these analyses on neutrophils stimulated
in vitro with a wider range of agonists, and from patients with inflammatory disease, for exam-
ple rheumatoid arthritis (RA). As has already been shown with transcriptomics[30, 41, 62],
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metabolomics has the potential to provide novel insight into disease heterogeneity, and could
provide new information on the molecular effects of drug therapies on neutrophil function in
vivo.
Supporting information
S1 Fig. Absence of Ficoll Paque in neutrophil NMR spectra. Green spectra shows neat Ficoll
Paque. Black trace shows Ficoll Paque at expected maximum carry-through concentration in
culture media. Neutrophil extracts shown for n = 3 experiments. No contaminating Ficoll
Paque is visible in the neutrophil extracts.
(PDF)
S2 Fig. Spectra showing NAD and NADP metabolite peaks. NAD and NADP peaks
are barely detected above noise at 256NS, however peaks are clearly visible at 512NS and
2048NS.
(PDF)
S3 Fig. Overlay of neutrophil metabolite extracts (n = 82). Insets show representative 1H
NMR spectra for aliphatic and aromatic regions. Key metabolites are annotated as follows: (1)
1-Methylhistidine, (2) 3-Methylxanthine, (3) 4-Aminohippuric acid, (4) Acetic acid, (5) Ade-
nine, (6) ADP, (7) D-Glucose, (8) D-Mannose, (9) Ethanol, (10) Formic acid, (11) Glycine,
(12) Histamine, (13) Inosine, (14) L-Alanine, (15) L-Aspartic acid, (16) L-Isoleucine, (17)
L-Lactic acid, (18) Lactulose, (19) Methylmalonic acid, (20) N-Acetyl-L-tyrosine, (21) N,
N-Dimethylformamide, (22) NAD, (23) NADP, (24) NADPH, (25) Oxypurinol. Assignments
detailed in S1 Table.
(PDF)
S4 Fig. Change in neutrophil metabolome induced by PMA. Neutrophils were incubated in
the presence of PMA (0.1 μg/mL) for 5 and 15 min (n = 3 biological replicates measured in
technical triplicates). Supervised multivariate analysis by PLS-DA segregated 5 and 15 min
samples (Q2 0.39248, R2 0.91143, accuracy 0.83333). Shading represents 95% confidence
region. Scores plot is shown for components 1 and 2.
(PDF)
S5 Fig. Change in neutrophil metabolome in untreated cells. Neutrophils were incubated
without treatment for 5 and 15 min (n = 2 biological replicates measured in technical tripli-
cates). Supervised multivariate analysis by PLS-DA was not able to segregate 5 and 15 min
samples (Q2–6.4346, R2 0.93566, accuracy 0.16667). Shading represents 95% confidence
region. Scores plot is shown for components 1 and 2.
(PDF)
S1 Table. Metabolite assignments for S1 Fig.
(PDF)
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